This case documents the long-term effectiveness of combined treatment with a somatostatin analogue and a dopamine agonist in a patient who no longer had a response to either agent alone and supports the hypothesis that somatostatin and dopamine receptors interact and that somatostatin and dopamine agonists may potentiate actions.

Cabergoline plus lanreotide for ectopic Cushing's syndrome

FERONE, DIEGO;
2005-01-01

Abstract

This case documents the long-term effectiveness of combined treatment with a somatostatin analogue and a dopamine agonist in a patient who no longer had a response to either agent alone and supports the hypothesis that somatostatin and dopamine receptors interact and that somatostatin and dopamine agonists may potentiate actions.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11567/211862
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 76
  • ???jsp.display-item.citation.isi??? 68
social impact